Natural killer cell-mediated damage of clinical isolates of mucormycetes

Mycoses

Volumn 59, Issue 1, 2016, Pages 34-38

  Schmidt, Stanislaw ^a   Schneider, Andreas ^a   Demir, Asuman ^a   Lass Flörl, Cornelia ^b   Lehrnbecher, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antifungal activity; Immunomodulation; Invasive fungal disease; Mucormycetes; Natural killer cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CONTROLLED STUDY; FUNGUS GROWTH; FUNGUS HYPHAE; FUNGUS ISOLATION; HUMAN; HUMAN CELL; LICHTHEIMIA CORYMBIFERA; LICHTHEIMIA RAMOSA; MUCOR CIRCINELLOIDES; MUCORALES; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NORMAL HUMAN; PRIORITY JOURNAL; RHIZOPUS MICROSPORUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; MUCOR; MUCORMYCOSIS; NATURAL KILLER CELL; RHIZOPUS;

HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MUCOR; MUCORALES; MUCORMYCOSIS; RHIZOPUS;

EID: 84952637765     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12431     Document Type: Article

References (23)

1. Cuenca-Estrella M, Bernal-Martinez L, Isla G, Gomez-Lopez A, Alcazar-Fuoli L, Buitrago MJ. Incidence of zygomycosis in transplant recipients. Clin Microbiol Infect 2009; 15: 37-40.
2. Lehrnbecher T, Schmidt S, Tramsen L, Klingebiel T. Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients. Front Oncol 2013; 3: 17.
3. Ma LL, Wang CLC, Neely GG, Epelman S, Krensky AM, Mody CH. NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol 2004; 173: 3357-65.
4. Voigt J, Hünniger K, Bouzani M et al. Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity. J Infect Dis 2014; 209: 616-26.
5. Schmidt S, Tramsen L, Hanisch M et al. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203: 430-5.
6. Schmidt S, Tramsen L, Perkhofer S et al. Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. Immunobiology 2013; 218: 939-44.
7. Bouzani M, Ok M, McCormick A et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. J Immunol 2011; 187: 1369-76.
8. Gill S, Olson JA, Negrin RS. Natural Killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. Biol Blood Marrow Transplant 2009; 15: 765-76.
9. Hallett WHD, Murphy WJ. Natural killer cells: biology and clinical use in cancer therapy. Cell Mol Immunol 2004; 1: 12-21.
10. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-100.
11. Tramsen L, Schmidt S, Boenig H et al. Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes. Cytotherapy 2013; 15: 344-51.
12. Khanna N, Stuehler C, Conrad B et al. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood 2011; 118: 1121-31.
13. Stuehler C, Khanna N, Bozza S et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011; 117: 5881-91.
14. Slesiona S, Gressler M, Mihlan M et al. Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages. PLoS ONE 2012; 7: e31223.
15. Simitsopoulou M, Georgiadou E, Walsh TJ, Roilides E. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp. Med Mycol 2010; 48: 720-4.
16. Murciano C, Villamón E, O'Connor JE, Gozalbo D, Gil ML. Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect Immun 2006; 74: 1403-6.
17. Lanternier F, Sun H-Y, Ribaud P, Singh N, Kontoyiannis DP, Lortholary O. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis 2012; 54: 1629-36.
18. Wood SM, Ljunggren H-G, Bryceson YT. Insights into NK cell biology from human genetics and disease associations. Cell Mol Life Sci 2011; 68: 3479-93.
19. Antachopoulos C, Demchok JP, Roilides E, Walsh TJ. Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi. Mycoses 2010; 53: 321-8.
20. Antachopoulos C, Meletiadis J, Roilides E et al. Relationship between metabolism and biomass of medically important zygomycetes. Med Mycol 2006; 44: 429-38.
21. Fontaine T, Delangle A, Simenel C et al. Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus. PLoS Pathog 2011; 7: e1002372.
22. Kawakami K, Koguchi Y, Qureshi MH et al. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Microbiol Immunol 2000; 44: 1043-50.
23. Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B. Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J Immunol 2009; 182: 4306-12.